Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06127108 · ClinicalTrials.gov registry record · NA

Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel

A NA study of COVID-19 and Influenza a, sponsored by Abbott Rapid Dx.

Completed
Registry status
NA
Development phase
447
Enrollment target
1
Study location

NCT06127108 is a NA study of COVID-19 and Influenza a that has completed, run by Abbott Rapid Dx. The registered enrollment target is 447 participants, below the 55,212-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06127108, a NA study of COVID-19 and Influenza a, has completed, sponsored by Abbott Rapid Dx.

COMPLETED
Registry status
NA
Development phase
447 participants
Enrollment target
1
Study location

Study Summary

The study is designed as a prospective, multicentric, clinical study to investigate the positive percent agreement (PPA) and negative percent agreement (NPA) of the Panbio™ COVID-19/Flu A\&B Panel using anterior nasal swab specimens tested directly, relative to the comparator methods, Roche cobas® SARS-CoV-2 (K231306) and Quidel Lyra® Influenza A+B Assay(K230236) (RT-PCR) in symptomatic patients suspected of respiratory viral infection by a healthcare provider.

Conditions Studied

COVID-19 Influenza a Influenza B

Interventions

  • DIAGNOSTIC_TEST Panbio™

Study Locations (1)

Virginia

  • Advanced Pediatrics - Vienna

Trial Details

FieldValue
Enrollment Target 447 participants
Start Date 2023-11-14
Est. Completion 2024-02-02
Phase NA

Sponsor

Abbott Rapid Dx

5 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06127108

The ClinicalTrials.gov registry entry for NCT06127108 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 447 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,212-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The listed sponsor is Abbott Rapid Dx, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Panbio™ is the first listed.

NCT06127108 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT06127108 about?

NCT06127108 is a clinical study titled "Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel". The study is designed as a prospective, multicentric, clinical study to investigate the positive percent agreement (PPA) and negative percent agreement (NPA) of the Panbio™ COVID-19/Flu A\&B Panel using anterior nasal swab specimens tested directly, relative to the comparator methods, Roche cobas® S...

What is the current status of trial NCT06127108?

This trial is currently completed. It is a NA study. The enrollment target is 447 participants. The study started on 2023-11-14. Estimated completion is 2024-02-02.

What conditions does trial NCT06127108 study?

This clinical trial studies the following conditions: COVID-19, Influenza a, Influenza B.

What interventions are being tested in trial NCT06127108?

The interventions under investigation include: Panbio™ (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06127108?

This trial is sponsored by Abbott Rapid Dx, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06127108 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

COVID-19

All registered trials for this condition

Influenza a

All registered trials for this condition

Virginia

All trials with a study site in Virginia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.